Outro
New York, US · Founded 2022 · 2 known investors
Find your way into Outro
Outro provides digital mental healthcare focused on safely discontinuing psychiatric medications through individualized tapering plans based on hyperbolic deprescribing research. The platform serves patients seeking evidence-based support and medical guidance for managing antidepressant withdrawal.
Founders & leadership
Outro was founded in 2022 by Dr. Mark Horowitz.
DM.webp)
Dr. Mark HorowitzCo-Founder
BS
Brandon Strain-GoodeNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 1 round · 2024
▶$2.8MraisedOct 2024 · 22 investors · Other Health CareRule 506(b)
▶$2.8MraisedOct 2024 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon Strain-GoodeExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.8M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Outro do?
- Outro provides digital mental healthcare focused on safely discontinuing psychiatric medications through individualized tapering plans based on hyperbolic deprescribing research. The platform serves patients seeking evidence-based support and medical guidance for managing antidepressant withdrawal.
- Who founded Outro?
- Outro was founded by Dr. Mark Horowitz in 2022.
- Who are Outro's investors?
- Outro's investors include Hannah Grey Ventures, SemperVirens Venture Capital.
- How much funding has Outro raised?
- Outro has disclosed $2.8M raised across 1 round.
- Where is Outro headquartered?
- Outro is headquartered in New York, US.